Skip to main content

Stock Market News - Sun Pharma Falls, Yes, Bank gains

NEWS ALERT | Biocon's Bengaluru unit receives EIR from US FDA: BSE filing
-- EIR received for Biologics Drug Products Facility
-- EIR informs about the closure of inspection
Alert: Facility inspected between Aug 22 and Aug 30
       : EIR is Establishment Inspection Report

Sun Pharma Falls After Unit Taro Pharma Announces Q2 Results - Shares of Sun Pharmaceutical Industries fell as much as 1.6 percent to Rs 431.05 after the company’s unit Taro Pharma announced its second-quarter results.


Rupee Opens: The Indian rupee opened lower by 8 paise at 70.85 per dollar on Tuesday versus previous close 70.77.

Yes, Bank gains nearly 9% after Jhunjhunwala buys the stake for Rs 86.89 crore - Shares of private lender Yes Bank rose nearly 9 percent in the early trade on November 5 after Rakesh Jhunjhunwala bought a stake in the company via open market transactions. Ace investor Rakesh Jhunjhunwala bought 1.29 crore shares in private lender on November 4 through open market transactions.

Biocon rises 3% after co receives EIR from USFDA - Shares of Biocon added over 3 percent in the early trade on November 5 after the company received EIR from the USFDA. The company received an establishment inspection report (EIR) from the US Food and Drug Administration for its biologics drug product facility in Bengaluru, stating the inspection is closed, as per company release.

Bajaj Finance Gains After Launching QIP Shares of Bajaj Finance rose as much as 2.4 percent to Rs 4,210. The company launched its QIP Issue with floor price at Rs 4,019.78 per share. The floor price is at a discount of 2.3 percent to the previous closing price. The company will hold a meeting on Nov. 7 to approve the issue price which will be allotted to QIP buyers.

Oil rises more than 1 percent - Oil prices rose more than 1% on Monday, buoyed by an improved outlook for crude demand as better-than-expected U.S. jobs growth added to market hopes a preliminary U.S.-China trade deal would be reached this month. 

Brent crude futures for January rose 95 cents, or 1.5% to $62.64 a barrel by 12:37 p.m. CST (1837 GMT). December U.S. crude futures were up $1.09, or 1.9%, at $57.29 a barrel.

Gold price today: Yellow Metal down on trade optimism -Gold futures fell in early trade on November 5 as hopes of a U.S.-China trade pact bolstered the dollar and increased appetite for riskier assets. Gold December futures were trading with a negative bias at Rs 38,375 per 10 gram at 09:10 hours IST.


Sensex | Market News | Bank Nifty | Rupee | Gold 

Comments

  1. MMMFS STOCK CASH CALL BUY IBULHSGFIN ABOVE 315 TGTS 317.25-319.50-321.75 SL 312
    STOCK CASH UPDATE: 2ND TGT 319.50 ACHIEVED IN OUR IBULHSGFIN BUY CALL, BOOK SOME PROFIT
    Premium Cash Tips

    ReplyDelete
  2. Thanks for this practical post. Its really worth sharing. I will sure try your techniques. Useful post for everyone. Thanks for sharing.
    Mukesh trends Lifestyle
    ESAF SFB
    S&P BSE Midcap
    FMCG shares

    ReplyDelete

Post a Comment

Popular posts from this blog

Stock Market News - Budget 2020 | Removal of exemptions in new tex regime to impact life insurers, MFs

A salaried professional opting for a lower rate of tax under the new regime will not be eligible for deductions, including insurance premium paid and ELSS investments. Removal of tax exemptions under Section 80C in the new tax regime could be a dampener for life insurance products as well as equity-linked savings schemes (ELSS) of mutual funds. In her Budget speech on February 1, Finance Minister Nirmala Sitharaman said a salaried professional opting for a lower tax rate under the new regime will not be eligible for deductions, including insurance premium paid and ELSS investments. “The removal of 80C benefit may pose a risk to new business volumes of life insurance companies,” said Kotak Institutional Equities in a report. Life insurance Tax exemptions are an important incentive for purchase of life insurance. To be eligible for exemption under Section 80C, the sum assured has to be 10 times the annual premium. This is part of the Rs 1.5 lakh limit under ...

Stock Market News - FDC share price at 52-week high on GMP certificate from UK health regulator

The certificate came after a recent inspection of the company's facilities in Goa. FDC  share price touched a 52-week high of Rs 222, rising more than 5 percent in the morning trade on January 3 after the company received the good manufacturing practice (GMP) certificate from the UK's health regulator. The UK's Medicines and Healthcare Products Regulatory Agency also continued with its approved status for the company's two facilities in Verna, Goa. The GMP certificate was issued after a recent inspection of the two plants. At 1018 hours, FDC was quoting at Rs 218.00, up Rs 7.30, or 3.46 percent. The share price has risen 30 percent in the last three months. GNFC share price down 2% after DoT seeks Rs 15K cr in telecom dues DoT sent the company a demand notice for Rs 15,019 crore, taking to Rs 3.13 lakh crore the amount it has sought from non-telecom companies following a Supreme Court ruling. The share price of  Gujarat Narmada Valley Fertili...

Budget 2019 : LTCG Tax, GST, Home Loans, farmer income scheme needs to be focus

Budget 2018 was the last full-fledged budget presented by the government led by Narendra Modi. Long Term Capital Gains (LTCG) tax on profit earned from the sale of equity shares listed on a recognized stock exchange in India. The LTCG tax was re-introduced after a time gap of 14 years. The provisions were closely followed since they impacted the majority of taxpayers of the country. The tax was levied at the rate of 10 per cent (plus applicable surcharge and cess) while providing relief from gains accrued up to January 31, 2018, i.e., a mechanism was derived wherein the stock price as on 31 January 2018 was considered as the deemed cost, provided it is beneficial to the taxpayer. Following are some of the illustrative points: Treatment of compulsorily convertible instruments – The current provisions do not provide clarity on the cost to be adopted for the purpose of computation of capital gains in case of instruments that are compulsorily converted into equity sh...